New Zealanders will be able to have Pfizer's Covid-19 vaccine as soon as it's ready to be rolled out, after it was given approval today by Medsafe.
The agency has granted provisional approval with 58 conditions for the company to ensure Medsafe is kept up to date with manufacturing and safety information.
Epidemiologist Professor Michael Baker joins Karyn to explain the process.
University of Otago epidemiologist Professor Michael Baker Photo: University of Otago, Wellington / Luke Pilkinton-Ching
